Search

Your search keyword '"D Jane Holmes-Walker"' showing total 4 results
Start Over Author "D Jane Holmes-Walker" Publisher wiley
4 results on '"D Jane Holmes-Walker"'

1. Benchmarking care outcomes for young adults with type 1 diabetes in Australia after transition to adult care

Author

Phidias Rueter, Kaye Farrell, Helen Phelan, Peter Colman, Maria E. Craig, Jenny Gunton, D. Jane Holmes‐Walker, and the ADDN study group, ANDA study group

Subjects
care outcomes, type 1 diabetes, young adults, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
Abstract

Abstract Aim To determine advantages conferred by a youth‐specific transition clinic model for young adults with type 1 diabetes (T1D) at Westmead Hospital (WH) as compared with Australian registry data. Methods Prospectively collected data included age, diabetes duration, visit frequency, post code, BMI, mode of insulin delivery, continuous glucose monitoring, HbA1c, albumin creatinine ratio, BP, retinopathy and diabetic ketoacidosis (DKA) for all WH T1D clinic attendees aged 16–25 between January 2017 and June 2018 (n = 269). Results were compared with data collected during the same time period from 2 separate Australian data registries, one longitudinal (Australasian Diabetes Data Network, ADDN) and one a spot survey (the Australian National Diabetes Audit, ANDA). Results Across the three cohorts, HbA1c was similar (respectively, WH, ADDN, ANDA; 8.7%[72mmol/mol], 8.7%[72mmol/mol], 8.5%[69mmol/mol]) and HbA1c was significantly higher in young adults

Published
2021
Full Text
View/download PDF

2. Glycaemic outcomes in Australasian children and adults with type 1 diabetes: failure to meet targets across the age spectrum

Author

Timothy W. Jones, D Jane Holmes-Walker, Melissa Chee, and Mary B Abraham

Subjects
HBA1c target, Type 1 diabetes, Pediatrics, medicine.medical_specialty, endocrine system diseases, business.industry, Continuous glucose monitoring, medicine.disease, Subcutaneous insulin, Diabetes mellitus, Cohort, Internal Medicine, Medicine, business, Glycated haemoglobin, Specialist care
Abstract

BACKGROUND The goal of therapy in Type 1 diabetes (T1D) is to achieve optimal glycaemic targets and reduce complications. Robust data representing glycaemic outcomes across the lifespan are lacking in Australasia. AIMS To examine contemporary glycaemic outcomes and rate of use of diabetes technologies in Australasian people with T1D. METHODS Cross-sectional analysis of de-identified data from 18 diabetes centres maintained in the Australasian Diabetes Data Network (ADDN) registry during 2019. Glycaemia was measured using glycated haemoglobin (HbA1c). The proportion of people with T1D achieving the international HbA1c target of

Published
2022

3. Author response for 'Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data Network'

Author

null Claire A. Robertson, null Arul Earnest, null Melissa Chee, null Maria E. Craig, null Peter Colman, null Helen L. Barrett, null Philip Bergman, null Fergus Cameron, null Elizabeth A. Davis, null Kim C. Donaghue, null P. Gerry Fegan, null P. Shane Hamblin, null D. Jane Holmes–Walker, null Craig Jefferies, null Stephanie Johnson, null Meng T. Mok, null Bruce R. King, null Richard Sinnott, null Glenn Ward, null Benjamin J. Wheeler, null Anthony Zimmermann, null Timothy W. Jones, null Jenny J. Couper, and null the ADDN Study Group

Subjects
medicine.medical_specialty, business.industry, Diabetes mellitus, Intervention (counseling), Family medicine, medicine, Audit, medicine.disease, business
Published
2021

4. Access to a youth-specific service for young adults with type 1 diabetes mellitus is associated with decreased hospital length of stay for diabetic ketoacidosis

Author

Kris Park, D Jane Holmes-Walker, Kharis Burns, Kaye Farrell, and Rickie Myszka

Subjects
Pediatrics, medicine.medical_specialty, Type 1 diabetes, Diabetic ketoacidosis, business.industry, Attendance, Length of hospitalization, 030209 endocrinology & metabolism, Retrospective cohort study, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Internal Medicine, medicine, 030212 general & internal medicine, Medical emergency, Young adult, business, Adolescent health
Abstract

Background Management of Type 1 diabetes mellitus (T1DM) in youth with diabetes is complex and glycaemic control often deteriorates during this challenging period. We hypothesise that attendance at a youth-specific diabetes clinic reduces hospital admission rates and length of stay for diabetic ketoacidosis (DKA). Aims This study aimed to assess the impact of a youth specific diabetes service for youth with diabetes (YWD) on DKA admissions in two adjacent local health districts (LHDs). Methods A retrospective cohort analysis of admissions for DKA in YWD aged 15-25, presenting to four hospitals in Western Sydney in 2011 was performed. Number of admissions, length of stay (LOS) and DKA severity were assessed. Cost was analysed as a function of LOS. Groups were divided by attendance at a youth-specific diabetes service or no record of attendance. Results There were 55 DKA admissions from 39 patients (median age 20.0 years); the majority of admissions (82%) were YWD not supported by a youth-specific diabetes service. Median LOS was significantly longer in the unsupported group (3.0 days vs. 1.5 days, p=0.028). Median pH at presentation in the unsupported group was significantly lower, 7.11 versus 7.23 (p=0.05). There was a 4-fold greater admission rate in those not supported by youth-specific diabetes services, 5.5% compared with 1.6% (p=0.001). The estimated cost saved by youth-specific services was over $250,000pa. Conclusions Lack of access to supported care for YWD at the transition has an adverse impact on DKA admission rates and LOS.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results